# CORRESP — Virax Biolabs Group Ltd  (VRAX)  (CIK 0001885827)

> <strong>Virax Biolabs Group Ltd  (VRAX)  (CIK 0001885827) → SEC staff</strong> · filed 2025-12-29 · ticker VRAX · SIC 2835

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001193125-25-335379
- **Form:** CORRESP
- **Filer:** Virax Biolabs Group Ltd  (VRAX)  (CIK 0001885827)
- **CIK:** 0001885827
- **Ticker:** VRAX
- **Filed:** 2025-12-29
- **SIC industry:** 2835
- **HQ:** Lanarkshire, X0

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1885827/000119312525335379/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1885827&type=UPLOAD&dateb=&owner=include&count=40

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Virax Biolabs Group Ltd  (VRAX)  (CIK 0001885827) (CIK 0001885827), filed 2025-12-29, accession 0001193125-25-335379. Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/comment-letter/0001193125-25-335379.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*
